Catherine London, who has more than two decades of experience in the pharma and healthcare sectors, has joined biOasis Technologies as executive VP-corporate affairs and IR. She reports to CEO Mark Day.
|
|
Catherine LondonMost recently, London did a two-year stint as corporate communications chief at Purdue Pharma, maker of Oxycontin.
Earlier, she held corporate and product PR positions at Alexion Pharmaceuticals and Boehringer Ingelheim and worked at communications firms Chandler Chicco and Ruder Finn.
At biOasis, London assumes a newly created post in charge of external communications, visibility, brand-building and financial communications.
CEO Day praised London as a “forward-thinking communications leader and collaborative relationship builder.”
biOasis, which is based in Vancouver, has developed treatments for neurological diseases such as brain cancers, neurodegenerative and metabolic diseases.
Lo Isidro, senior director at Real Chemistry with more than a decade of strategic communications and PA experience, has joined Narrative Strategies.
Nelson Fernandez, former North American chair of APCO Worldwide and managing director of Burson-Marsteller, has joined Volunteers in Medicine Berkshires as director of communications and PA.
Lilit Bargar, who was most recently an EVP in the healthcare practice at Weber Shandwick, comes on board at GCI Health as EVP, corporate practice lead.
Five ways that successful thought leaders are made.
Have a comment? Send it to 
No comments have been submitted for this story yet.